Status:

COMPLETED

Mucosal-Associated Invariant T Cells in Cases of Miscarriage

Lead Sponsor:

Assiut University

Conditions:

Miscarriage

Eligibility:

FEMALE

20-35 years

Brief Summary

Miscarriage is the most frequently encountered complication of pregnancy ranging from 10% to 30%. The etiology of recurrent spontaneous miscarriage (RSM) in 40%-50% of cases cannot be identified. Immu...

Eligibility Criteria

Inclusion

  • Regular marital life with the same partner.
  • Regularly menstruating before current pregnancy.
  • Spontaneous conception.

Exclusion

  • Women with Polycystic ovarian syndrome or any endocrinal abnormalities like DM, thyroid disorders.
  • History of abnormal uterine cavity proved by sonohysterography or hysteroscopy before pregnancy.
  • Women with positive consanguinity.

Key Trial Info

Start Date :

June 1 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 1 2022

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT04492098

Start Date

June 1 2021

End Date

December 1 2022

Last Update

January 31 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ahmed Abbas

Assiut, Cairo Governorate, Egypt, 002